Form 8-K - Current report:
SEC Accession No. 0001564590-17-008359
Filing Date
2017-05-03
Accepted
2017-05-03 16:06:50
Documents
3
Period of Report
2017-05-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arwr-8k_20170503.htm 8-K 29199
2 EX-99.1 arwr-ex991_6.htm EX-99.1 231585
3 GRAPHIC g201705031923109383710.jpg GRAPHIC 3238
  Complete submission text file 0001564590-17-008359.txt   266848
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38042 | Film No.: 17809159
SIC: 2834 Pharmaceutical Preparations